Wagner Wealth Management (South Carolina)’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-130
Closed -$1K 605
2022
Q3
$1K Hold
130
﹤0.01% 659
2022
Q2
$1K Buy
+130
New +$803 ﹤0.01% 675
2022
Q1
Sell
-130
Closed -$2K 564
2021
Q4
$2K Hold
130
﹤0.01% 638
2021
Q3
$2K Hold
130
﹤0.01% 606
2021
Q2
$3K Hold
130
﹤0.01% 622
2021
Q1
$3K Buy
+130
New +$3.02K ﹤0.01% 591

Other funds holding RCEL

Wagner Wealth Management (South Carolina)'s RCEL Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Avita Medical (RCEL) in Q4 2022, closing a stake of 130 shares — an estimated $1K sold.

Wagner Wealth Management (South Carolina) first reported a position in RCEL in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q2 2021. 52 funds tracked by Wall St. Rank hold RCEL as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Avita Medical position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 130 Avita Medical shares in Q4 2022, an estimated $1K.
  • Wagner Wealth Management (South Carolina) first reported a position in Avita Medical in Q1 2021 and held it in 6 quarters.
  • Wagner Wealth Management (South Carolina)'s Avita Medical position peaked at $3K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Avita Medical as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.